ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations
ASCO: AI Training Improves Accuracy of HER2 Immunohistochemistry Scoring
For HER2 clinical categories, accuracy improved from 66.7 percent without AI to 88.5 percent with AI
Prevalence of Disability Up Over Twofold for Current Smokers
Disability prevalence 14.1 percent for current smokers, 6.8 percent for never smokers, and 12.6 percent for former smokers
18.6 Million Cancer Survivors in the United States as of Jan. 1, 2025
Racial differences in treatment common, including lower likelihood of surgery for stage I to II lung cancer in Black patients
Physical Activity Linked to Better Survival for Specific Cancer Types
Engaging in leisure-time MVPA linked to improved survival for various cancer types including bladder, breast, colon
Substantial and Increasing Burden of Skin Cancer Seen in Older Adults
Only incidence and prevalence rates attributable to keratinocyte cancer, DALYs attributable to BCC would increase by 2050
16 Updates, Four New Recommendations Issued for Management of Pediatric VTE
Direct oral anticoagulants suggested over standard of care anticoagulants for pediatric patients with venous thromboembolism
Low Alcohol Use Disorder Treatment Rates Seen in Cancer Survivors
One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent
Total Number of Excess Deaths >14.7 Million in U.S. in 1980 to 2023
U.S. mortality rose rapidly in 2020 and 2021, then declined in 2022 and 2023, remaining higher than in 2019
